FSA compares two global equity funds: the Fidelity World Fund and the Investec Global Strategic Equity Fund.
Tag: Fidelity International
In case you missed it (23 February 2018)
Fidelity poaches from Amundi AM; Jupiter hires JP Morgan multi-asset PM; Alliance Bernstein and Allianz GI rated as top managers in Asia; Bloomberg to include Indonesian rupiah-denominated debt in global index; Indonesia becomes first Asian country to sell green bonds globally; and more…
In case you missed it (19 January 2018)
UBP’s AUM increases to $130bn; BNY Mellon IM creates head of intermediary distribution for Greater China role; Hermes IM hires for APAC business development team; BEA Union Investment launches China-focused multi-asset fund; Natixis’ Seeyond aims to double its AUM; China Post Global lists ETF in London for the first time; and more…
Fidelity leads the WFOE race
Fidelity’s investment-management wholly foreign-owned enterprise (IM WFOE) has launched two new funds while Blackrock and Schroders obtain private fund management (PFM) licences for their WFOEs.
HEAD-TO-HEAD: Allianz vs Fidelity
FSA compares the Allianz Dynamic Asian High Yield Bond Fund and the Fidelity Asian High Yield Bond Fund.
In case you missed it – Fund Management News
No replacement for Enhance Group’s ex-Singapore MD; BNPP AM names new Hong Kong CEO; T Rowe makes two senior appointments in Japan; GAM launches healthcare equity fund in Taiwan; Fidelity’s Eight Roads rolls out China-focused healthcare fund; BNPP AM acquires majority stake in Belgian robo-advisory firm; and more
HEAD-TO-HEAD: Fidelity vs UBS
FSA compares the Fidelity China Focus Fund and the UBS China Opportunity Fund.
HEAD-TO-HEAD: Fidelity vs JP Morgan
FSA compares two Asean equity funds: the Fidelity Asean Fund and the JP Morgan Asean Fund.
Five views on Moody’s downgrade of China
Asset managers comment on Moody’s decision to lower China’s sovereign credit rating by one notch to A1 from Aa3, with stable outlook.
Time to buy China’s treasury bonds?
Chinese government bond yields have surged due to regulatory actions, presenting a buying opportunity, according to several fund managers.
